SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-14-000023
Filing Date
2014-11-13
Accepted
2014-11-13 16:09:49
Documents
2
Period of Report
2014-11-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K ocera-form8xkxq32014earnin.htm 8-K 28159
2 OCERA REPORTS Q3 FINANCIAL RESULTS q32014exhibitforearningsre.htm EX-99.1 92198
  Complete submission text file 0001274644-14-000023.txt   121533
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 141218521
SIC: 2834 Pharmaceutical Preparations